基于肿瘤起源解剖部位的新乳腺癌术语分类方法:影像生物标志物的重要性
本文基于大范围三维亚宏观病理与乳腺影像生物标志物的系统对照,提出乳腺癌可按起源解剖部位分为终末导管小叶单位、主要输乳管及间质干细胞三个亚组,相对频率分别约为75%、20%和5%,三组临床、病理及乳腺影像表现与长期结局不同,影像生物标志物有助于判断肿瘤起源部位并作为预后指标。
要点
- 乳腺癌按起源解剖部位分为三个亚组,相对频率分别约为75%、20%和5%。
- 三个亚组的临床、组织病理及乳腺影像表现不同,长期结局也不同。
- 影像生物标志物可判断肿瘤起源部位并作为预后指标。
核心结论
- 按肿瘤起源解剖部位分类乳腺癌有助于克服当前导管-小叶二分法组织病理学术语的不一致,影像生物标志物能判断起源部位并作为预后指标,凸显乳腺影像在乳腺癌管理中的关键作用。
研究设计与样本
- 通过大范围薄层组织病理学与长期患者结局对照,系统关联乳腺癌亚型的大范围三维亚宏观组织病理图像与其对应影像生物标志物,研究基于前瞻性收集的不可触及早期乳腺癌并随访数十年。
关键影像表现/征象
- 乳腺癌起源于三个独立的纤维腺体组织成分:终末导管小叶单位、主要输乳管及间质干细胞。
- 三个癌症亚组具有明显不同的临床、组织病理学和乳腺影像表现及不同的长期结局。
诊断标准与关键数值
- 三个乳腺癌亚组的相对频率分别约为75%、20%和5%。
临床应用与阅片要点
- 作者认为按起源解剖部位分类乳腺癌有助于克服当前组织病理学术语中导管-小叶二分法的不一致。
- 作者认为影像生物标志物能够判断肿瘤起源部位并作为预后指标,强调乳腺影像在乳腺癌管理中的作用日益关键。
- 作者提出以解剖相关术语为基础进行乳腺癌管理挑战了传统思维。
局限性
- 本文为系列 forthcoming 文章的总体介绍,未详细描述各起源部位乳腺癌。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To use mammographic tumour features (imaging biomarkers) to classify breast cancer according to its apparent anatomic site of origin in the new era where tumours are found at their nonpalpable, earliest detectable phase.
METHOD: Large format, subgross, three-dimensional histopathologic images of breast cancer subtypes and their corresponding imaging biomarkers were correlated with large format thin section histopathology and long-term patient outcome.
RESULTS: This systematic correlation indicates that breast cancers arise from three separate fibroglandular tissue components: the terminal ductal lobular units (TDLUs), the major lactiferous ducts, and in the stem cells of the mesenchyme. The resulting three cancer subgroups have distinctly different clinical, histopathological and mammographic presentations and different long-term outcomes. The relative frequency of these three breast cancer subgroups is approximately 75%, 20% and 5%, respectively. Classification of breast cancers according to their anatomic site of origin, as demonstrated with breast imaging and confirmed by subgross histopathology, correlates closely with the long-term patient outcome.
CONCLUSIONS: Classification of breast cancers according to their site of origin helps overcome the inconsistencies in the current histopathologic terminology with its ductal-lobular dichotomy. The ability of the imaging biomarkers to determine the site of tumour origin and serve as a prognostic indicator emphasizes the increasingly crucial role of breast imaging in the management of breast cancer. Basing breast cancer management upon anatomically relevant terminology challenges the conventional mindset. Our proposals are based on research results from an unprecedented number of prospectively collected nonpalpable breast cancers diagnosed at their earliest detectable phases and followed up for several decades. This article is a general introduction to a series of forthcoming articles describing in detail the breast malignancies originating from the three sites of origin.
引用
- Tabár, Dean, Lee Tucker, et al. A new approach to breast cancer terminology based on the anatomic site of tumour origin: The importance of radiologic imaging biomarkers. Eur J Radiol. 2022. PMID: 35151954. doi:10.1016/j.ejrad.2022.110189
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。